Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Yervoy
Yervoy
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
3 Cancer Investing Opportunities
Seeking Alpha
Tue, 10/1/13 - 10:10 am
Merck
cancer
AstraZeneca
Bristol-Myers Squibb
MK-1775
ovarian cancer
MK-3475
melanoma
Yervoy
Yervoy Battles Melanoma, but Can It Become a Blockbuster?
Motley Fool
Sun, 09/29/13 - 01:57 pm
Yervoy
melanoma
Bristol-Myers Squibb
Bristol’s Yervoy Adds Up to 10 Years of Life for Cancer Patients
Bloomberg
Sat, 09/28/13 - 12:13 pm
Yervoy
Bristol-Myers Squibb
Bristol-Myers Squibb: Another Brick In The Wall
Seeking Alpha
Mon, 09/16/13 - 10:07 am
Bristol-Myers Squibb
Yervoy
prostate cancer
Bristol-Myers skin cancer drug Yervoy misses goal in study of additional, prostate cancer use
Yahoo/AP
Thu, 09/12/13 - 09:21 am
prostate cancer
Yervoy
Bristol-Myers Squibb
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
Forbes
Thu, 05/16/13 - 11:07 am
Bristol-Myers Squibb
Merck
Roche
Ono Pharmaceuticals
Yervoy
nivolumab
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
Bloomberg
Thu, 05/16/13 - 08:49 am
melanoma
Bristol-Myers Squibb
nivolumab
Yervoy
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
Yervoy-Zelboraf combo trial stopped on toxicity worries
Fierce Pharma
Thu, 04/4/13 - 02:05 pm
Zelboraf
Yervoy
Bristol-Myers Squibb
melanoma
Roche
Understanding Why Cancer Vaccines Fail
Motley Fool
Mon, 04/1/13 - 10:46 am
cancer
vaccines
Dendreon
Provenge
Bristol-Myers Squibb
Yervoy
Sanofi
TheraCys
Bristol-Myers Squibb's Dividend Increase And Promising New Drugs
Seeking Alpha
Tue, 01/29/13 - 10:23 am
dividend
Bristol-Myers Squibb
Eliquis
Yervoy
PDL-1
Abilify
Forixga
New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)
Yahoo/BusinessWire
Sat, 09/29/12 - 12:24 pm
Yervoy
melanoma
Bristol-Myers Squibb
Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
Seeking Alpha
Tue, 09/25/12 - 11:53 am
Bristol-Myers Squibb
melanoma
Yervoy
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Fri, 09/21/12 - 01:13 pm
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Seeking Alpha
Tue, 07/24/12 - 11:25 pm
Zelboraf
Yervoy
melanoma
GSK
Bristol-Myers Squibb
Roche
Radiation Blast May Turbocharge Bristol-Myers Melanoma Drug, Report Shows
Bloomberg
Thu, 03/8/12 - 09:57 am
melanoma
Bristol-Myers Squibb
radiation therapy
Yervoy
Bristol-Myers' Post-Patent Plan
Motley Fool
Wed, 12/28/11 - 10:23 am
patents
Bristol-Myers Squibb
Plavix
Sanofi
Yervoy
liscensing
M&A
Two Top Biotech Plays With Safe Upside
Seeking Alpha
Wed, 11/30/11 - 02:09 pm
ImmunoCellular
glioblastoma multiforme
brain cancer
Bristol-Myers Squibb
Yervoy
melanoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »